Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by Oceanison Oct 29, 2021 4:59am
127 Views
Post# 34061974

RE:RE:Unbelievable to me that Stada

RE:RE:Unbelievable to me that Stadapharmacuetical companies have a vested interest in making sure cannabis doesn't become mainstream within medicine.  There's a fox in the henhouse imo.  In any case LABS doesnt need stada, so this new CEO better have a plan b. Or explain their buisness plan better, because all these partnerships with all these companies to date are fuk all to the shareholders.
 
They're so worried about being a "Global" cannabis company that they forgot to take care of their own backyard first.  Last I heard cannnabis has been fully legalized in CANADA. LABS has shown zero ability to adapt to the changing cannabis landscape in Canada.  Are we to wait for a decade for the rest of the world to legalize for share value to accumulate or, are we going to adapt and make monies for the shareholders, NOW.

They need ACTION.  26c.
<< Previous
Bullboard Posts
Next >>